Walleye dermal sarcoma virus Orf B functions through receptor for activated C kinase (RACK1) and protein kinase C

Candelaria C Daniels1, Joel Rovnak, Sandra L Quackenbush

  • 1Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO 80523, USA.

Virology
|March 18, 2008
PubMed

Insights

Walleye dermal sarcoma virus accessory proteins Orf A and Orf B may drive cancer. Orf B interacts with RACK1 and protein kinase C (PKC), promoting cell survival and proliferation.

Area of Science:

  • Virology
  • Oncology
  • Cell Biology

Background:

  • Walleye dermal sarcoma virus causes seasonal skin tumors in walleye.
  • Accessory gene transcripts A and B, and their encoded proteins Orf A and Orf B, are implicated in oncogenesis.
  • Tumor development correlates with low transcript levels, suggesting a critical role for these proteins.

Purpose of the Study:

  • To investigate the role of walleye dermal sarcoma virus Orf B protein in oncogenesis.
  • To identify cellular proteins interacting with Orf B.
  • To elucidate the mechanism by which Orf B influences cell behavior.

Main Methods:

  • Localization studies of Orf B in explanted tumor cells and mammalian cells.
  • Yeast two-hybrid assays and cell culture to identify Orf B interacting proteins.
  • Sequence analysis of walleye RACK1.
  • Investigation of Orf B association with protein kinase C (PKC) and the effects of activated PKC.

Main Results:

  • Orf B protein localizes to the cell periphery, similar to focal adhesions and actin stress fibers.
  • The cellular protein receptor for activated C kinase 1 (RACK1) binds to Orf B.
  • Walleye RACK1 is highly conserved.
  • Orf B associates with constitutively activated PKCalpha at the membrane.
  • Activated PKC signaling in Orf B-expressing cells promotes cell survival, proliferation, and viability.

Conclusions:

  • Orf B protein plays a significant role in walleye dermal sarcoma oncogenesis.
  • Orf B interacts with RACK1 and PKC, hijacking cellular signaling pathways.
  • The Orf B-RACK1-PKC interaction promotes cancer cell survival and proliferation, offering potential therapeutic targets.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...